Join
Live feed
·
NEWSReleasevia Quantisnow
Centogene N.V. logo

Centogene And C-Path Sign MOU For Collaboration In Lysosomal Disease Research And Drug Development

ByQuantisnow·Wall Street's wire, on your screen.
CNTG· Centogene N.V.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CNTG (Centogene N.V.) and more on Quantisnow.

Centogene And C-Path Sign MOU For Collaboration In Lysosomal Disease Research And Drug Development | Quantisnow